Global Antimalarial Medication Market Growth 2024-2030

Global Antimalarial Medication Market Growth 2024-2030

Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.

The global Antimalarial Medication market size is projected to grow from US$ 1312.2 million in 2023 to US$ 1791 million in 2030; it is expected to grow at a CAGR of 4.5% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Antimalarial Medication Industry Forecast” looks at past sales and reviews total world Antimalarial Medication sales in 2023, providing a comprehensive analysis by region and market sector of projected Antimalarial Medication sales for 2024 through 2030. With Antimalarial Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antimalarial Medication industry.

This Insight Report provides a comprehensive analysis of the global Antimalarial Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antimalarial Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antimalarial Medication market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antimalarial Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antimalarial Medication.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report presents a comprehensive overview, market shares, and growth opportunities of Antimalarial Medication market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Plasmodium Falciparum
Plasmodium Malariae
Plasmodium Vivax
Plasmodium Ovale

Segmentation by application
Hospital Pharmacy
Retail Pharmacy
E- Commerce
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GlaxoSmithKline
F. Hoffmann-La Roche
Novartis
Pfizer
Sun Pharmaceutical Industries
Merck

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antimalarial Medication market?

What factors are driving Antimalarial Medication market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antimalarial Medication market opportunities vary by end market size?

How does Antimalarial Medication break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.